Luiz F. De Carvalho

Brasilia, DF, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial.

Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial.

Journal: Cardiovascular diabetology

Published: November 05, 2025

Cardiovascular risk factors across job roles and work shifts in a Brazilian Military Police cohort: a cross-sectional study.

Cardiovascular risk factors across job roles and work shifts in a Brazilian Military Police cohort: a cross-sectional study.

Journal: Frontiers in public health

Published: September 30, 2025

Plasma Levels of Small HDL Particles Are Associated With Coronary Atherosclerosis Progression in Adults With Diabetes.

Plasma Levels of Small HDL Particles Are Associated With Coronary Atherosclerosis Progression in Adults With Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 08, 2024

Remnant Cholesterol: A Missed Opportunity in Cardiovascular Risk Reduction?

Remnant Cholesterol: A Missed Opportunity in Cardiovascular Risk Reduction?

Journal: Atherosclerosis

Published: November 26, 2024

Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective.

Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective.

Journal: Frontiers in cardiovascular medicine

Published: July 18, 2024

Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System.

Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System.

Journal: Value in health regional issues

Published: July 04, 2024

Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials.

Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials.

Journal: Seminars in arthritis and rheumatism

Published: April 26, 2024

Unraveling the intertwined threads of insomnia and sarcopenia in cognitive and functional impairment in octogenarians.

Unraveling the intertwined threads of insomnia and sarcopenia in cognitive and functional impairment in octogenarians.

Journal: BMC geriatrics

Published: December 07, 2023

Fracture Risk Assessment Tool-Based Screening for Osteoporosis in Older Adults in Resource-Limited Settings.

Fracture Risk Assessment Tool-Based Screening for Osteoporosis in Older Adults in Resource-Limited Settings.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry

Published: December 06, 2023

DMARD-specific risk of atrial fibrillation in rheumatoid arthritis: a new piece in the puzzle.

DMARD-specific risk of atrial fibrillation in rheumatoid arthritis: a new piece in the puzzle.

Journal: Rheumatology (Oxford, England)

Published: September 15, 2023

Metoprolol for prevention of bucking at orotracheal extubation: a double-blind, placebo-controlled randomised trial.

Metoprolol for prevention of bucking at orotracheal extubation: a double-blind, placebo-controlled randomised trial.

Journal: Brazilian journal of anesthesiology (Elsevier)

Published: January 28, 2023

Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.

Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.

Journal: Health economics review

Published: January 20, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026